Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040334047> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2040334047 abstract "The administration of two chemoimmunotherapy programs to 103 consecutive patients with metastatic colorectal cancer resulted in improved survival for patients who achieved either objective tumor regressions or disease stabilization for more than 8 weeks. Objective tumor regression was observed in 47% of patients treated with the Ftorafur-methyl-CCNU-methotrexate-Bacillus Calmette-Guerin (FTOR-MeM-BCG) program and in 34% of patients treated with the 5-fluorouracil-methotrexate-Baker's antifol (FU-M-BAF) +/- Levamisole program. The combinated median duration of survival for patients who achieved objective tumor regression and disease stabilization with FTOR-MeM-BCG was 13 months compared with 6 months for patients who had progression of disease (p = 0.001). The corresponding values for patients treated with FU-M-BAF +/- levamisole were 11 months and seven months, respectively (p = 0.001). While the role of BCG immunotherapy in these results remains speculative, the administration of levamisole immunotherapy did not appear to have influenced results significantly. Patients who presented at diagnosis with Dukes A, B and C lesions, and therefore had longer disease-free intervals, responded more frequently to chemoimmunotherapy and survived longer than patients who presented at diagnosis with Dukes D lesions. Similarly, greater antitumor effect was observed in patients with lower pretreatment plasma CEA levels evaluation of these pretreatment characteristics may have insignificant implications for the design of future clinical trials." @default.
- W2040334047 created "2016-06-24" @default.
- W2040334047 creator A5010968810 @default.
- W2040334047 creator A5021675241 @default.
- W2040334047 creator A5043892380 @default.
- W2040334047 creator A5060563693 @default.
- W2040334047 creator A5064210978 @default.
- W2040334047 creator A5072786200 @default.
- W2040334047 creator A5082916862 @default.
- W2040334047 date "1977-11-01" @default.
- W2040334047 modified "2023-09-27" @default.
- W2040334047 title "Chemoimmunotherapy of metastatic large bowel cancer.Nonspecific stimulation with BCG and levamisole" @default.
- W2040334047 cites W1982010436 @default.
- W2040334047 cites W1988007859 @default.
- W2040334047 cites W2040815968 @default.
- W2040334047 cites W2042276405 @default.
- W2040334047 cites W2055983050 @default.
- W2040334047 cites W2067976878 @default.
- W2040334047 cites W2093568647 @default.
- W2040334047 cites W2135332148 @default.
- W2040334047 cites W2143594378 @default.
- W2040334047 cites W2338415229 @default.
- W2040334047 cites W2396200506 @default.
- W2040334047 cites W4239889997 @default.
- W2040334047 cites W4293241248 @default.
- W2040334047 doi "https://doi.org/10.1002/1097-0142(197711)40:5+<2731::aid-cncr2820400948>3.0.co;2-w" @default.
- W2040334047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/336190" @default.
- W2040334047 hasPublicationYear "1977" @default.
- W2040334047 type Work @default.
- W2040334047 sameAs 2040334047 @default.
- W2040334047 citedByCount "19" @default.
- W2040334047 countsByYear W20403340472012 @default.
- W2040334047 crossrefType "journal-article" @default.
- W2040334047 hasAuthorship W2040334047A5010968810 @default.
- W2040334047 hasAuthorship W2040334047A5021675241 @default.
- W2040334047 hasAuthorship W2040334047A5043892380 @default.
- W2040334047 hasAuthorship W2040334047A5060563693 @default.
- W2040334047 hasAuthorship W2040334047A5064210978 @default.
- W2040334047 hasAuthorship W2040334047A5072786200 @default.
- W2040334047 hasAuthorship W2040334047A5082916862 @default.
- W2040334047 hasBestOaLocation W20403340471 @default.
- W2040334047 hasConcept C121608353 @default.
- W2040334047 hasConcept C126322002 @default.
- W2040334047 hasConcept C141071460 @default.
- W2040334047 hasConcept C143998085 @default.
- W2040334047 hasConcept C2777701055 @default.
- W2040334047 hasConcept C2780790343 @default.
- W2040334047 hasConcept C2781059491 @default.
- W2040334047 hasConcept C2781325985 @default.
- W2040334047 hasConcept C526805850 @default.
- W2040334047 hasConcept C71924100 @default.
- W2040334047 hasConcept C90924648 @default.
- W2040334047 hasConceptScore W2040334047C121608353 @default.
- W2040334047 hasConceptScore W2040334047C126322002 @default.
- W2040334047 hasConceptScore W2040334047C141071460 @default.
- W2040334047 hasConceptScore W2040334047C143998085 @default.
- W2040334047 hasConceptScore W2040334047C2777701055 @default.
- W2040334047 hasConceptScore W2040334047C2780790343 @default.
- W2040334047 hasConceptScore W2040334047C2781059491 @default.
- W2040334047 hasConceptScore W2040334047C2781325985 @default.
- W2040334047 hasConceptScore W2040334047C526805850 @default.
- W2040334047 hasConceptScore W2040334047C71924100 @default.
- W2040334047 hasConceptScore W2040334047C90924648 @default.
- W2040334047 hasLocation W20403340471 @default.
- W2040334047 hasLocation W20403340472 @default.
- W2040334047 hasOpenAccess W2040334047 @default.
- W2040334047 hasPrimaryLocation W20403340471 @default.
- W2040334047 hasRelatedWork W2010500971 @default.
- W2040334047 hasRelatedWork W2020048154 @default.
- W2040334047 hasRelatedWork W2071993275 @default.
- W2040334047 hasRelatedWork W2414398316 @default.
- W2040334047 hasRelatedWork W2886463397 @default.
- W2040334047 hasRelatedWork W3033503052 @default.
- W2040334047 hasRelatedWork W3171846279 @default.
- W2040334047 hasRelatedWork W3184046266 @default.
- W2040334047 hasRelatedWork W3194437930 @default.
- W2040334047 hasRelatedWork W4206639819 @default.
- W2040334047 isParatext "false" @default.
- W2040334047 isRetracted "false" @default.
- W2040334047 magId "2040334047" @default.
- W2040334047 workType "article" @default.